FDA Greenlights Elon Musk’s Neuralink for Initial Human Trials of Groundbreaking Brain Implants
In a landmark moment for the melding of humans and technology, Elon Musk’s innovative start-up, Neuralink, has announced that it has been granted permission by the US Food and Drug Administration (FDA) to commence its first in-human clinical study of its state-of-the-art brain implants. Characterizing this FDA clearance as a “significant first step,” Neuralink conveyed …


